Argent Biopharma Limited has released a press release.
MGC Reaches 1,000 Prescription Milestone Ahead of Schedule
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- 800 Prescription Milestone Passed for MGC Pharma Products
- 600 Prescription Milestone Passed for MGC Pharma Products
- MGC Pharma Passes 400 Prescription Milestone in September
- 200 Prescription Milestone Passed in Australia & UK
- Epilepsy Clinical Study Comparing CannEpil to 100% CBD
Later from Argent Biopharma
- Pause in Trade
- Binding Term Sheet to Immediately Expand into Latin America
- Growth in Prescriptions Issued Continues During November
- Approval Received for Distribution of CannEpil into Ireland
- Prescriptions Grow Above 1,800 & First Ireland Prescriptions
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma